Stockwinners Market Radar for April 14, 2022 - Earnings, Upgrades downgrades, option trades, Best Stock Advisory Service

20:11 EDT Cathie Wood's ARK Investment bought 57.7K shares of Intellia Therapeutics today

19:30 EDT Faro Technologies names Jeff Sexton as VP of Global Sales - FARO Technologies "announced the retirement of Kevin Beadle, Senior Vice President of Global Sales. FARO announces the appointment of Jeff Sexton to lead FARO's global sales organization, effective April 18, 2022. Mr. Sexton joined FARO approximately two years ago and has successfully led its Americas sales organization."

18:53 EDT CSX receives STB approval to acquire Pan Am Railways - CSX Corp. announced that the Surface Transportation Board approved CSX's application to acquire Pan Am Railways, Inc. CSX will move forward with the acquisition with a planned closing date of June 1, 2022, at which time CSX will acquire control of Pan Am. "CSX is pleased that the STB approved the proposed acquisition of Pan Am and has recognized the significant benefits this transaction will bring to shippers and other New England stakeholders," said president and chief executive officer, James M. Foote. "We look forward to integrating Pan Am, their employees and the rail-served industries of the Northeast into CSX and to working in partnership with connecting railroads to provide exceptional supply chain solutions to New England and beyond." Terms of the transaction were not disclosed.

18:37 EDT AppLovin co-founder Andrew Karam sells $5.34M in common stock - In a regulatory filing, AppLovin disclosed that its co-founder Andrew Karam sold 53.1K shares of common stock in a total transaction size of $5.34M.

17:49 EDT Musk says Twitter board would breach duty by acting against holder interests - Tesla (TSLA) founder Elon Musk tweeted, "If the current Twitter (TWTR) board takes actions contrary to shareholder interests, they would be breaching their fiduciary duty. The liability they would thereby assume would be titanic in scale." The tweet was in response to Cameron Winklevoss saying that Twitter is considering a poison pill to thwart Musk's takeover offer, adding that the company would "rather self-immolate than give up their censorship programs." Reference Link

17:06 EDT Casella Waste president Johnson sells over $1.2M in company shares - Casella Waste president Edwin Johnson disclosed in a filing that he had sold 13,507 shares of company stock at $90.89 per share between April 12 and April 13, for a total transaction amount of $1,227,684.

17:02 EDT Ginkgo Bioworks partners with Light Bio on bioluminescence engineering - Light Bio and Ginkgo Bioworks announced a collaboration to leverage Ginkgo's plant cell assays for bioluminescence engineering. Through the agreement, Ginkgo aims to help improve the luminescent output and efficiency of the enzymes within Light Bio's glowing ornamental plants. The scientists at Light Bio have discovered a new type of bioluminescence mechanism and are using synthetic biology to engineer plants to efficiently emit light. The original light emission pathway Light Bio uses in its glowing plants comes from bioluminescent mushrooms, and the company is now focused on expanding its engineering capabilities to support the creation of glowing plants.

16:39 EDT Ormat Technologies signs 15-year power purchase agreement with Peninsula - Ormat Technologies has signed a 15-year power purchase agreement with Peninsula Clean Energy, a Community Choice Aggregator that provides more than 3,500 GW hours of electricity to San Mateo County and the City of Los Banos. Under the terms of the agreement approved by Peninsula Clean Energy's Board of Directors, effective January 1, 2023, the CCA will purchase 26 MW of clean, renewable energy from Ormat's Heber 2 geothermal facility located in Imperial Valley, CA. This PPA marks the successful completion of Ormat's first ever solicitation for bids, with a request for bids on the Heber 2 facility issued in July of 2021.

16:33 EDT Weyerhaeuser to purchase 80,800 acres of timberlands for $265M - Weyerhaeuser announced an agreement to purchase 80,800 acres of timberlands in North and South Carolina from a fund managed by Campbell Global for approximately $265M. The acquisition is comprised of productive timberlands situated in coastal markets and located to deliver immediate synergies with existing Weyerhaeuser timber and mill operations. Additionally, the acquisition is expected to deliver cash flow and harvest tons per acre within the company's Southern Timberlands business. Attributes include well-stocked timber inventory with a mature age class producing sawlog mix and average harvest of 6.5 tons per acre annually over the first 10 years with expected average adjusted EBITDA of approximately $160 per acre annually from timber operations over the first 10 years. With this acquisition, Weyerhaeuser will own or manage more than 900,000 acres of timberlands in the Carolinas, and the company also operates four mills, a distribution center and tree nursery and hosts multiple mitigation banks and real estate development projects employing more than 700 people between the two states. The transaction is subject to customary closing conditions and is expected to close in the second quarter of 2022.

16:31 EDT InVivo Therapeutics announces 1-for-25 reverse stock split - InVivo Therapeutics "announced a 1-for-25 reverse stock split of its common stock and a proportionate reduction in its authorized common stock. The company anticipates the reverse stock split will become effective at 5:00 p.m. Eastern Time on April 26, 2022, and shares of InVivo Therapeutics common stock will trade on a post-split basis under the company's existing trading symbol, "NVIV," at the market open on April 27, 2022."

16:18 EDT Sinclair Broadcast, Charter reach comprehensive distribution agreement - Sinclair Broadcast Group (SBGI) and Charter Communications (CHTR) have reached a comprehensive distribution agreement for continued carriage of Sinclair's owned local broadcast stations, Tennis Channel, 19 Bally Sports RSN brands, Marquee Sports Network and the YES Network, in which Sinclair is a joint venture partner. Terms of the agreement were not disclosed.

16:16 EDT Crestwood Equity increases quarterly cash distribution by 5% - Crestwood Equity Partners announced that the board of its general partner has declared the partnership's quarterly cash distribution of 65.5c per limited partner unit for the quarter ended March 31, which represents an approximate 5% increase quarter-over-quarter.

16:13 EDT Cloudflare president Zatlyn sells $1.48M in company shares - Cloudflare president Michelle Zatlyn disclosed in a filing that she had sold 12,821 shares of company stock at $115.16 per share on April 12, for a total transaction amount of $1,476,484.

16:08 EDT Stronghold Digital Mining appoints Matthew Smith to CFO - Stronghold Digital Mining announced the appointment of Matthew Smith to the position of chief financial officer, effective April 18, succeeding Ricardo Larroude, who is leaving the Company to pursue other business interests. He will remain with Stronghold through May 15 to ensure a seamless transition. Mr. Larroude's departure does not relate to any disagreements between him and the Company relating to any financial reporting, accounting principles or practices of Stronghold. The Company thanks Mr. Larroude for his devotion to, and services on behalf of, the Company, as he was instrumental to Stronghold's growth in the past year, and the Company wishes him the best in his future endeavors.

16:07 EDT Inter Parfums will not renew Dunhill fragrance license when it expires next Sept - The company states: "Inter Parfums announced that its Dunhill fragrance license will expire on September 30, 2023 and will not be renewed. During the balance of the license, Inter Parfums will continue to produce and sell Dunhill fragrances under the same business conditions as in the past. Once the license expires, Inter Parfums has the right to sell-off its remaining Dunhill fragrance inventory for a limited time as is common in our industry."

16:03 EDT Neximmune promotes Mathias Oelke to Chief Scientific Officer - NexImmune has promoted Mathias Oelke to Chief Scientific Officer. Oelke is a scientific co-founder of NexImmune and joined NexImmune in 2014. Prior to his promotion, he served as Senior VP, Preclinical Immunotherapy and Head of Cell Biology of NexImmune since 2017.

15:33 EDT Cumulus Media jumps 19%, halted after Reuters report on Warshaw-led bid

15:23 EDT Musk asks Prince Alwaleed about Twitter ownership, views on freedom of speech - After Saudi Prince Alwaleed said via Twitter earlier that he does not believe that the proposed offer by Elon Musk "comes close" to the intrinsic value of Twitter and that he would reject the offer as a significant holder of Twitter shares, Elon Musk stated in a tweeted reply: "Interesting. Just two questions, if I may. How much of Twitter does the Kingdom own, directly & indirectly? What are the Kingdom's views on journalistic freedom of speech?" Reference Link

15:11 EDT Musk tweets will try to keep as many shareholders in Twitter as 'allowed by law' - Elon Musk, the CEO of Tesla (TSLA) and largest shareholder of Twitter (TWTR), tweeted: "Will endeavor to keep as many shareholders in privatized Twitter as allowed by law," echoing comments the executive made earlier while being interviewed at a TED event. Reference Link

14:45 EDT Indonesia Energy Corporation Limited trading resumes

14:32 EDT WhatsApp debuts Communities, new tools for administrators to monitor abuse - In a blog posting, the WhatsApp team said, in part: "We are building Communities on WhatsApp for close-knit groups that need more tools to organize and manage their conversations. These kinds of groups typically have a connection where people know one another and are organized around a common place or interest. Parents at a school, local clubs, and even small workplaces now rely on WhatsApp as their primary way of keeping people up to date...At the center of every Community on WhatsApp is a description and menu of groups that people can choose to join... We are building a number of updates to provide private, safe, and secure ways for these groups to communicate on WhatsApp with the following principles as our guide." Updates include, "new tools for admins to manage conversations among their private groups. Admins are responsible for creating and managing Communities on WhatsApp." "In addition to providing new tools for admins, users can control their interactions within Communities. Our existing settings allow users to decide who can add them to a group - and these settings will also apply to Communities," said the statement from WhatsApp. "While other apps provide group chats without limits, WhatsApp is focusing our product development on meeting the needs of organizations and other groups where many people know one another already. Unlike social media and other messaging services, WhatsApp will not support the ability to search for or discover new Communities on our service." Additionally, WhatsApp said it continues "to constrain forwarding on WhatsApp to keep conversations private With the introduction of Communities, messages that have already been forwarded will only be able to be forwarded to one group at a time, rather than five, which is today's forward limit" and also "will continue to protect messages with end-to-end encryption so that only the members of the respective groups can see them and no one else. This security technology protects the sensitive conversations among organizations, workplaces, and personal groups." Reference Link

14:26 EDT Innovative Industrial says short report has 'false and misleading statements'

14:06 EDT Worldwide semiconductor revenue grew 26% in 2021, Gartner says - In an earlier release, research and advisory firm Gartner said in part: "Worldwide semiconductor revenue totaled $595B in 2021, an increase of 26.3% from 2020, according to final results by Gartner. "The events behind the current chip shortage continue to impact original equipment manufacturers or OEMs, around the world, but the 5G smartphone ramp up and a combination of strong demand and logistics/raw material price increases drove semiconductor average selling prices, ASPs, higher, contributing to significant revenue growth in 2021," said Andrew Norwood, research vice president at Gartner.The most significant shift among the semiconductor vendor ranking in 2021 was HiSilicon dropping out of the top 25. "HiSilicon's revenue declined 81%, from $8.2B in 2020 to $1.5B in 2021," said Norwood. "This was a direct result of the U.S. sanctions against the company and its parent company Huawei...2021 saw strong demand return to the automotive and industrial markets compared to the weak, COVID-disrupted market in 2020. The automotive market outperformed all other end markets, growing 34.9% in 2021. Wireless communications, which is dominated by smartphones, saw growth of 24.6%. The number of 5G handsets produced reached 556 million in 2021, up from 251 million units in 2020, and enterprises upgraded their Wi-Fi infrastructure for employees heading back to the office. Driven by DRAM, memory accounted for 27.9% of semiconductor sales in 2021 and experienced 33.2% revenue growth, increasing $41.3 billion over the previous year. Memory continued to benefit from the key demand trend in the last couple of years - the shift to home/hybrid working and learning. This trend fueled increased server deployments by hyperscale cloud service providers to satisfy online working and entertainment, as well as a surge in end-market demand for PCs and ultramobiles. Samsung Electronics (SSNLF) regained the top spot from Intel (INTC) for the first time since 2018, though by less than a percentage point, with revenue increasing 28% in 2021 . Intel's revenue declined 0.3%, garnering 12.2% market share compared to 12.3% market share for Samsung. Within the top 10, AMD and Mediatek experienced the strongest growth in 2021 at 68.6% and 60.2% growth, respectively." Publicly traded companies in the space include AMD (AMD), Intel , Marvell (MRVL), Microchip (MCHP), Micron (MU), Nvidia (NVDA), Qualcomm (QCOM) Texas Instruments (TXN) Samsung (SSNLF) KLA Corp. (KLAC), Applied Materials (AMAT), TSMC (TSM) and Lam Research (LRCX). Reference Link

14:00 EDT Vuzix CEO says medical side of business not slowing down

13:42 EDT Musk sees having 'sufficient assets' to do a deal for Twitter - Asked whether he has "funding secured" for a deal to buy Twitter (TWTR), Elon Musk said he has "sufficient assets" to get a deal completed if a deal is possible. He then added about his prior tweet regarding having "funding secured" to buy Tesla (TSLA) that "funding was actually secured" for that deal. Musk said he was "forced to concede" to the SEC regarding his prior Tesla take-private tweet. Musk made the comments while speaking at an event hosted by TED.

13:32 EDT Musk says 'not sure' he'll be able to buy Twitter, but can afford it - Elon Musk is speaking at a TED event, during which he is discussing his offer to buy Twitter and take the company private. During the interview at the TED event, Musk said he is "not sure" he'll actually be able to buy Twitter, but that he can "technically" afford it, adding he does not care about the economics "at all." He added that his aim would be to retain as many shareholders as is legal. Musk also said he believes if speech is in a gray area, it should be allowed to exist on the platform and that timeouts for questionable speech would be better than user bans.

13:10 EDT CF Industries says Union Pacific curtails fertilizer shipments - CF Industries (CF) announced that it has informed customers it serves by Union Pacific (UNP) rail lines that railroad-mandated shipping reductions would result in nitrogen fertilizer shipment delays during the spring application season and that it would be unable to accept new rail sales involving Union Pacific for the foreseeable future. "The company understands that it is one of only 30 companies to face these restrictions," CF Industries noted in its press release. CF Industries ships to customers via Union Pacific rail lines primarily from its Donaldsonville Complex in Louisiana and its Port Neal Complex in Iowa. The rail lines serve key agricultural areas such as Iowa, Illinois, Kansas, Nebraska, Texas and California. Products that will be affected include nitrogen fertilizers such as urea and urea ammonium nitrate, or UAN, as well as diesel exhaust fluid, or DEF, the company noted. "On Friday, April 8, Union Pacific informed CF Industries without advance notice that it was mandating certain shippers to reduce the volume of private cars on its railroad effective immediately. The company was told to reduce its shipments by nearly 20%. CF Industries believes it will still be able to fulfill delivery of product already contracted for rail shipment to Union Pacific destinations, albeit with likely delays. However, because Union Pacific has told the company that noncompliance will result in the embargo of its facilities by the railroad, CF Industries may not have available shipping capacity to take new rail orders involving Union Pacific rail lines to meet late season demand for fertilizer," the company added. CF Industries intends to engage directly with the federal government to ask that fertilizer shipments be prioritized so that spring planting is not adversely impacted, CF stated. Tony Will, president and chief executive officer, CF Industries Holdings, said: "CF Industries' North American manufacturing network continues to produce at a high rate to meet the needs of customers, farmers and consumers. We urge the federal government to take action to remove these Union Pacific rail shipment restrictions to ensure this vital fertilizer will be able to reach U.S. farmers when and where they need it."

13:01 EDT Tron's Justin Sun says would offer $60 per share for Twitter - Tron Founder Justin Sun tweeted earlier this morning: "I believe @Twitter is far from unleashing its full potential, thus I am offering $60 per share to take the platform private. But we fully support the reform initiatives of @elonmusk and would love to see Twitter becoming crypto-native and Web3 friendly." Sun's tweet came after Elon Musk disclosed in a filing with the SEC that he had delivered a letter to Twitter which contained a non-binding proposal to acquire all of the outstanding common stock he does not already own for all cash consideration valuing the common stock at $54.20 per share.

12:54 EDT CD Projekt's 'Cyberpunk 2077' has sold over 18M units - CD Projekt (OTGLY) said that its 2020 game "Cyberpunk 2077" has sold over 18M units since its release. The game is available on PC, Xbox One (MSFT), Xbox Series X/S, PlayStation 4 (SONY), and PS5. Reference Link

12:26 EDT D.C. asks court to reconsider dismissal of Amazon.com lawsuit - Washington D.C. Attorney General Karl Racine said via Twitter: "NEW: Today, we asked the court to reconsider its dismissal of our lawsuit against Amazon. We sued to stop Amazon's illegal anticompetitive behavior that hurts DC consumers and businesses that sell on the platform. We're confident the law and facts are on our side. In several of our lawsuits, we go up against the biggest, most powerful companies in the world. The Big 5 Tech companies are worth over $6 trillion. They're throwing everything at us to try to stop our lawsuits, but we're not going anywhere. We know our work standing up for consumers-particularly Black and brown consumers who are hit hardest by monopolization and worsening inequality -is too important for us to stand down."

12:25 EDT State Street sees Q2 NII up 7%-9% sequentially

12:19 EDT Bandai Namco's 'Scarlet Nexus' reaches 2M players worldwide - Bandai Namco (NCBDY) said that its action role-playing game "Scarlet Nexus," which released in 2021, has reached 2M players worldwide, including "loyal fans on Xbox (MSFT) and PC Game Pass." The game is also available on PlayStation 4 (SONY) and PS5. Reference Link

12:06 EDT Leafly names Deidre Boulware Chief People Officer - Leafly Holdings announced that Deidre Boulware will join the company as Chief People Officer. "Deidre will lead Leafly's people organization including talent acquisition and sourcing, talent management and development, and total rewards. Deidre will also lead the development and implementation of the company's enterprise-wide equity, diversity and inclusion strategy that fosters employee success, growth and career development," the company said. Prior to joining Leafly, Deidre served as Vice President and Head of Talent, Development & Diversity for American Century Investments.

12:04 EDT State Street: Direct exposure to Russia, Ukraine 'very small' - Comments taken from Q1 earnings conference call.

12:00 EDT GXO Logistics falls -9.4% - GXO Logistics is down -9.4%, or -$5.87 to $56.34.

12:00 EDT Daily S&P Biotech Bear 3x Shares rises 7.7% - Daily S&P Biotech Bear 3x Shares is up 7.7%, or $2.57 to $35.86.

12:00 EDT Renren rises 13.7% - Renren is up 13.7%, or $3.15 to $26.09.

11:55 EDT Prince Alwaleed, Kingdom Holding reject Musk offer for Twitter - Saudi Prince Alwaleed said via Twitter: "I don't believe that the proposed offer by @elonmusk ($54.20) comes close to the intrinsic value of @Twitter given its growth prospects. Being one of the largest & long-term shareholders of Twitter @Kingdom_KHC & I reject this offer."

11:15 EDT Citi CEO Jane Faser says she recently recovered from Covid

11:11 EDT Citi: Macro, geopolitical environment creates headwinds for capital ratios - The macro and geopolitical environment is creating headwinds and tailwinds for capital ratios this year, CEO Jane Fraser said.

11:05 EDT Peloton Interactive trading resumes

11:02 EDT Sinclair Broadcast, USSI Global announce datacasting pilot - Sinclair Broadcast Group, Inc. (Nasdaq: SBGI) and USSI Global announced that they will partner to offer the nation's first commercial datacasting service using the NextGen Broadcast standard. The pilot program will deliver local content, advertising, and data files to the rapidly growing Electric Vehicle Charging station market. Validating the promise of datacasting as a commercial service for broadcasters, USSI Global will combine its digital signage and managed services expertise with Sinclair's NextGen Broadcast capabilities to provide this first-of-a-kind datacasting offering. The USSI Global/Sinclair pilot program will confirm the ability to support EV Charging systems with dedicated content in select markets, refine the system design, optimize presentation of content, collect audience data, validate financial assumptions, and uncover unknowns. Sinclair will leverage existing content and advertising capabilities using NextGen Broadcast capabilities. The pilot program will require wireless delivery, storage and integration of data into USSI Global's ecosystem and will demonstrate a capability that can be scaled across the country.

10:32 EDT Anghami, TOD partner for sports, entertainment content - Anghami and TOD have announced a strategic partnership that will see a curated selection of TOD's sports and entertainment programming available on Anghami starting this holy month of Ramadan. Unveiled earlier this month, TOD, a subscription based over-the-top platform, offers more than 10,000 hours of premium entertainment and sports content including blockbusters, top Arabic, Turkish, international, and children's programming, together with a range of outstanding new TOD Originals. The companies said, "This strategic move, which aims to further diversify Anghami's vast selection of content and enrich its user experience, will give fans the opportunity to enjoy exclusive beIN Sports audio content on Anghami. This will include major football league games roundups as well as daily live updates and interviews with premier footballers. Anghami subscribers will also receive a one-month package to TOD Entertainment where they will have access to all the platform's world class content."

10:19 EDT Wells Fargo CFO: FY NII could be up by mid-teens percentage basis from 2021

10:13 EDT Kohl's CEO says selected bidders asked to 'further refine their offers' - In a regulatory filing, Kohl's shared a transcript of a video that CEO Michelle Gass sent to associates on April 13, in which Gass is quoted as having stated in part: "I want to take a few minutes today to speak to you about some of the things that are going on with Kohl's, both of which I have talked to you about before, and where there has been quite a bit of news of late. These are two discreet, yet connected issues that we're currently navigating. The first is an activist campaign that will culminate in a shareholder vote on May 11. The second, which is somewhat amplified by the activist, is an evaluation of what we call, expressions of interest - or potential bidders - who are exploring the opportunity to buy Kohl's, which may involve taking us from a public company to a private company. Before we get into the details of all of this, let me just make one thing really clear - we are a very healthy company. We have a great strategy in place, we just posted record results for 2021, and we are in the midst of scaling one of the biggest and most transformational initiatives that this company has ever had, with Sephora... When a company doesn't settle with an Activist investor, this results in both the company and the activist presenting their proposed directors to be voted on by shareholders at the annual meeting. Macellum has nominated ten directors, which is what we call a control slate, up against our 13 existing directors. Settling this year is unlikely, which means this will culminate in a vote at our annual shareholders meeting that is set for May 11... I am confident that they are the right Board to continue to lead our team and oversee our strategy. In contrast, the activists' nominees lack experience, with 6 of their 10 never having served on a public company Board... As we've had some expressions of interest to buy the company, the board has tapped the Finance Committee of the Board, and they have hired one of the most respected financial advisors in the world, Goldman Sachs, to help us drive this process -- and collectively, they are doing a very thorough job. They're evaluating what has come to us and they have done proactive outreach - all in the spirit of making sure that if this is the path that Kohl's should go down, that we are maximizing the way we go about it. They've engaged with over 25 parties and we've now moved onto the next phase where we've asked selected bidders to further refine their offers and to secure financing. They are doing a lot of diligence and homework, and we have provided access to thousands of documents and lots of data to help facilitate this process-- all of which is a very normal part of vetting. But let me be clear -- this does not necessarily mean we are selling the company, and no decisions have been made at this time. The board is doing its job in representing our shareholders to evaluate alternatives and other options - and all of those explorations are being held up against the current strategy that we're executing. The plan we're executing is very powerful and it will deliver substantial value to our shareholders - so that's a high bar that the board is looking at when evaluating these alternatives."

10:12 EDT Norfolk Southern offers $5,000 conductor starting bonuses in three new locations - Norfolk Southern announced the expansion of its conductor trainee incentive program to three new priority locations. Conductor trainees in Bellevue, Ohio; Elkhart, Indiana; and Fort Wayne, Indiana are now eligible to receive starting bonuses of $5,000. Other priority locations for Norfolk Southern include: Binghamton, New York; Birmingham, Alabama; Buffalo, New York; Chattanooga, Tennessee; Cincinnati, Ohio; Conway, Pennsylvania; Harrisburg, Pennsylvania; Linwood, North Carolina; Louisville, Kentucky; Manassas, Virginia; Roanoke, Virginia; and Sheffield, Alabama.

10:10 EDT Olo, SOCi partner for SOCi integration with Olo API - SOCi and Olo announced a strategic partnership whereby SOCi will integrate with the Olo API, allowing Olo data to pass through to the SOCi platform and its industry-leading localized listings management solutions.

10:08 EDT Exxon Mobil begins design studies for South East Australia CCS hub - ExxonMobil said it is undertaking early front-end engineering design studies to determine the potential for carbon capture and storage to reduce greenhouse gas emissions from multiple industries in the Gippsland Basin. The South East Australia carbon capture and storage hub would initially use existing infrastructure to store CO2 in the depleted Bream field off the coast of Gippsland, Victoria. The company is in active discussions with local industries which may be interested in accessing the SEA CCS hub to reduce emissions from their operations. The project is designed to capture up to 2 million metric tons of CO2 per year. If technical and business feasibility is confirmed, the SEA CCS hub could be operational by 2025.

10:00 EDT GNS Stock trading resumes

10:00 EDT GXO Logistics falls -7.2% - GXO Logistics is down -7.2%, or -$4.45 to $57.76.

10:00 EDT Rite Aid rises 9.7% - Rite Aid is up 9.7%, or 73c to $8.22.

10:00 EDT Renren rises 11.2% - Renren is up 11.2%, or $2.57 to $25.51.

09:50 EDT Ford reports Q1 China sales down 18.8% to about 125,000 units - Ford Motor Company sold approximately 125,000 units in China in the first quarter of 2022, a sales decrease of 18.8% year-over-year due to continued semiconductor shortages and resurgent pandemic-related restrictions, the company said. Ford added this "masks the company's better-than-industry performance in critical growth segments of luxury and commercial vehicles." Ford added: "In a down market, Lincoln continues its growth trajectory, with year-over-year sales rising 0.8%, while Ford brand commercial vehicles outperformed the overall commercial segment, on sales of approximately 51,000 units." Reference Link

09:47 EDT PG&E falls -5.0% - PG&E is down -5.0%, or -65c to $12.21.

09:47 EDT GXO Logistics falls -7.2% - GXO Logistics is down -7.2%, or -$4.49 to $57.72.

09:47 EDT Renren rises 10.1% - Renren is up 10.1%, or $2.31 to $25.25.

09:42 EDT Veru trading halted, volatility trading pause

09:35 EDT GNS Stock trading halted, volatility trading pause

09:32 EDT UnitedHealth says considerable variations in care patterns due to COVID-19 - Says revenue backlog was $22.8B. Says expects seasonal patterns to be more consistent with historical precedents. Says still seeing pockets of differentiation. Says a lot of M&A runway left. Says pipeline of opportunities is as diverse as its ever been. Comments taken from Q1 earnings conference call.

09:30 EDT Lead Edge Growth Opportunities Ltd (Class A Stock) trading halted, volatility trading pause

09:28 EDT Innovative Industrial Properties down 2% after named as short idea by Blue Orca

09:15 EDT Blink Charging expands through hardware, software upgrades, distribution deals - Blink Charging announced further international expansion through a variety of hardware and software upgrades and newly signed distribution agreements. Blink and its subsidiaries currently have equipment deployed or provide EV charging services in 18 countries. The Company has recently completed an international upgrade of the Blink Network, making the proprietary software available in 17 countries and US territories with local currency support and four languages. It expects to add another five countries to the Blink Network in the coming weeks. In addition, the Blue Corner Network, Blink's wholly owned subsidiary's network, is offered in four other European countries. The software enhancements include onboarding all hardware and EV driver members from the Greek joint venture, Blink Charging Hellas, onto the Blink Network. The addition of 210 EV chargers in Greece to the Blink Network will provide a more streamlined EV driver experience. Due to increased interest in EV charging infrastructure in Mexico, Chile, El Salvador, Guatemala, Uruguay, Costa Rica, Panama, Colombia, and Brazil, a variety of reseller and distribution agreements have been signed for Blink expansion in Latin America. These agreements allow Blink to quickly expand its footprint with local partners to provide Blink hardware and software across the region. Indeed, recently, the Company has deployed or sold Blink charging stations in Mexico, Chile, Colombia, Guatemala, El Salvador, Panama, Jamaica, and Aruba. As the Company expands internationally, it has also grown its international operations and support teams opening Blink entities in El Salvador, Chile, and Mexico. So far, Blink has hired 54 employees in territories outside the US to support its global expansion.

09:13 EDT Rivian Automotive appoints Anisa Kamadoli Costa as chief sustainability officer - Rivian Automotive (RIVN) announced the hiring of Anisa Kamadoli Costa as the company's chief sustainability officer, effective April 18. Anisa most recently held the position of chief sustainability officer at Tiffany (TIF) and chairman and president of the Tiffany & Co. Foundation. At Rivian, she will be responsible for the company's sustainability roadmap for both the business and its products, and will help lead Forever, the foundation that Rivian established at its initial public offering with 1% of equity - 8.3M shares. Anisa is the company's first chief sustainability officer and will report directly to Rivian's CEO, RJ Scaringe.

09:11 EDT SilverBow acquires Sundance, Sandpoint for $354M and $71M respectively - SilverBow Resources announced it has entered into a definitive agreement to acquire substantially all of the assets of Sundance Energy for a total purchase price of $354M and up to $15M of contingent payments based on future commodity prices. The Sundance transaction, which is expected to close in the third quarter of 2022, has been unanimously approved by the Boards of Directors of both companies. The closing of the transaction is subject to SilverBow shareholder approval and satisfaction or waiver of customary closing conditions. Sean Woolverton, SilverBow's Chief Executive Officer, commented, in part: "SilverBow has a disciplined approach towards growth based on our strict investment criteria. Today's transformative news builds on our recent series of transactions while advancing a number of our strategic objective...Mr. Woolverton commented further, "There is strong industrial logic for these acquisitions as the acreage overlap will allow SilverBow to drive synergies and optimize development plans. We estimate we have the ability to generate approximately $450M of incremental free cash flow through 2024, with total SilverBow pro forma free cash flow greater than a $1.0B. The aggregate purchase price of approximately $354M consists of $225M in cash, subject to customary closing adjustments, and 4.1M shares of SilverBow common stock valued at $129 million based on its 30-day volume weighted average price as of April 8, 2022. Up to an additional $15M of contingent payments may be payable to Sundance based upon future commodity prices. In addition to customary closing adjustments, SilverBow will benefit from a $16.5M downward adjustment to cash consideration at close related to the assumption of Sundance's existing hedge book. SilverBow intends to fund the cash portion of the consideration, fees and expenses with cash on hand and borrowings under its revolving credit facility. SilverBow also announced today that it has entered into a definitive agreement to acquire certain assets from SandPoint for a total purchase price of $71M. The oil and gas assets target the Eagle Ford and Olmos formations in La Salle and McMullen counties. The SandPoint transaction has been unanimously approved by the Boards of Directors of both companies and is expected to close in the second quarter of 2022, subject to customary closing conditions.

09:08 EDT D-Orbit enters agreement with Beyond Gravity to supply Space Rider components - D-Orbit announced the signing of a subcontract with space company Beyond Gravity, under which D-Orbit will deliver lightweight carbon fiber-reinforced polymer, CFRP, tools and metallic structural components for the European Space Agency's Space Rider reusable space vehicle. The financial terms of the transaction were not disclosed. D-Orbit was selected for its experience and established know-how in space projects. It will supply the CFRP tooling and metallic structural flight hardware components. The Space Rider spacecraft, which will be built by prime contractor Thales Alenia Space, is an automatic, uncrewed laboratory designed to perform technology demonstration and pharmaceutics, biomedicine, biology, and physical science experiments over missions lasting up to two months. Space Rider's maiden mission is expected to launch in 2023. D-Orbit has entered into a business combination agreement among Breeze Holdings Acquisition, a publicly traded special purpose acquisition company, D-Orbit and a newly formed joint stock company governed by the laws of the Grand Duchy of Luxembourg pursuant to which Holdco will become the publicly traded parent company of Breeze Holdings and D-Orbit upon the closing of the transactions.

09:06 EDT BeyondSpring files 2021 annual report on Form 20-F - BeyondSpring announced that it has filed its annual report on Form 20-F for the fiscal year ended December 31, 2021 with the U.S. Securities and Exchange Commission on April 14, 2022.

09:04 EDT Crown Electrokinetics publishes research on wasted energy - Crown Electrokinetics published research developed in partnership with the Lawrence Berkeley National Laboratory - Berkeley Lab, estimating the value of wasted energy at more than $45 billion per year. In 2022 over $45 billion will be wasted in energy in the United States alone, with windows being the weakest link in the thermal envelope of a building, according to the research Crown developed in partnership with Berkeley Lab. In 2018, the team at Berkeley Lab estimated the value of this wasted energy at roughly $40 billion per year. Research available to the public, cited in articles about windows, energy waste and climate change, in specialist publications like ClimateWire and Architect Magazine and even by the cleantech accelerator Third Derivative provided a $40 billion estimate. With help from Berkeley Lab, Crown identified more recent data from the EIA on commercial and residential energy consumption and expenditures, and then applied that data to the current body of research on window energy waste. The team also looked at several years of data - from 2016 to 2019, the most recent year available - to identify any notable trends. What was found was not surprising, but still concerning: The cost of window energy waste has increased to more than $45 billion per year. Berkeley Lab's researchers aren't just studying the problem - they're working with the private sector to solve it, through a new DOE-funded collaborative, the Partnership for Advanced Window Solutions. The U.S. Department of Energy, Better Buildings, Northwest Energy Efficiency Alliance, Office of Energy Efficiency and Renewable Energy, U.S. Department of Energy, have committed significant funding programs available to find solutions to improve the efficiency of windows. Crown's proprietary DynamicTint technology has applications in the domestic and international commercial building markets, residential window, and skylights, as well as multiple transportation industries, contributing to reducing energy waste. The Company expects its prospective customers will take rational financial and environmental actions - like investing in smarter, more efficient windows and other energy-saving technologies - to save billions of dollars and accelerate the transition to net-zero carbon emissions at the same time.

09:03 EDT Fat Brands appoints Michael Chachula as CIO - FAT Brands announces the hiring of its first chief information officer Michael Chachula. Chachula will be focused on delivering scalable, sustainable, and efficient technology platforms across the portfolio and franchise system to aid in the growth of the company. Most recently, Chachula was the Head of Digital and Revenue Growth for The Coffee Bean & Tea Leaf.

09:02 EDT INVO Bioscience selects Kansas City as additional INVO Center location - INVO Bioscience plans to open an INVO Center in Kansas City, Missouri. The Kansas City INVO Center will focus on patients in need of advanced fertility care utilizing the INVOcell solution. The company currently has three operational INVO Centers treating patients in Birmingham, Alabama, Atlanta, Georgia, and Monterrey, Mexico, with others scheduled to open in the San Francisco and Tampa areas. INVO believes that Kansas City may have upwards of 33,000 patients suffering with Infertility.

08:51 EDT Morgan Stanley CFO sees incremental NII up to $1B this year

08:50 EDT Morgan Stanley sees FY tax rate in line with FY21, says CFO

08:48 EDT BK Technologies awarded $1.7M purchase order from USFS - BK Technologies Corporation announced that it has received a purchase order valued at $1.7 million from the United States Department of Agriculture Forest Service for its BKR 5000 portable communications technology. The purchase order is part of the Company's 5-year Blanket Purchase Agreement with the U.S. Department of Agriculture, announced in May 2021, and reflects the agency's commitment to its lifecycle replacement program designed to migrate to newer, more effective portable communications platforms. The United States Forest Service is an agency of the U.S. Department of Agriculture that administers the nation's 154 national forests and 20 national grasslands. The Forest Service manages 193 million acres of land.

08:47 EDT Xometry announces availability of Instant Pricing app in Onshape store - Xometry announced the immediate availability of the Xometry Instant Pricing app for PTC's Onshape, the cloud-native CAD product development platform that gives users the freedom to create on any device, anytime, anywhere. The Xometry Instant Pricing app for Onshape offers: Seamless instant quoting. With the proprietary, AI-driven Xometry Instant Quoting Engine(R), engineers and designers can instantly price parts in one integrated CAD workspace and make real-time design decisions; Instant in-app design-for-manufacturing feedback, saving time and creating greater speed to market Custom-part ordering, from 3D printing and CNC machining to sheet-metal fabrication, urethane casting and injection molding. Designers can also configure materials, finishes and other specifications to generate lead times.

08:46 EDT Morgan Stanley sees loan growth in line with prior guidance of $5B per quarter

08:45 EDT Kingsoft Cloud announces changes to board of directors - Kingsoft Cloud announced the appointment of Jingyuan Qu as an independent director of its board of directors, effective immediately, based on the recommendations of the nominating and corporate governance committee of the Board. The Board also appointed Qu as a member of the audit committee, the compensation committee, and the nominating and corporate governance committee, effective immediately. Qu will replace Kuiguang Niu who has resigned from his position as a member of the Board and the relevant committees, effective immediately. Jingyuan Qu has been the founding partner of Dajishi Technology since September 2019.

08:42 EDT Coherus Biosciences, Junshi announce orphan drug designation for toripalimab - Shanghai Junshi Biosciences and Coherus BioSciences announced today that the United States Food and Drug Administration has granted Orphan Drug Designation for toripalimab, a PD-1 inhibitor, for the treatment of small cell lung cancer, ODD is granted to drugs intended to treat rare diseases with a patient population less than 200,000 in the United States. The designation provides incentives to advance development and commercialization of drugs that have the potential to provide benefit to patients with rare diseases. SCLC is an aggressive tumor characterized by rapid disease progression, low expression of PD-L1 and low levels of tumor infiltrating immune cells, as well as a high degree of immunosuppression. Efficacy of cancer immunotherapy has been limited in SCLC. No PD-1 inhibitors are currently approved in the United States for SCLC. Prognosis for SCLC patients is poor, with five year survival rates of approximately 20% and less than 5% for patients with extensive stage SCLC. The JUPITER-08 study is an ongoing, randomized, double-blind, placebo-controlled, multi-center Phase 3 clinical trial evaluating PD-1 inhibitor toripalimab in combination with chemotherapy compared to placebo in combination with chemotherapy as the first-line treatment of extensive stage SCLC. Enrollment in this trial has been completed. The co-primary endpoints of the study are overall survival and progression free survival as assessed by the investigator.

08:41 EDT Agios Pharmaceuticals announces publication of Phase 3 ACTIVATE study - Agios Pharmaceuticals announced that data from the core period of the pivotal Phase 3 ACTIVATE study of PYRUKYND in adults with pyruvate kinase, PK, deficiency who do not receive regular transfusions were published on April 14, 2022 in the New England Journal of Medicine. Data from this study were previously presented at the European Hematology Association, EHA, Virtual Congress held in June 2021. As reported in the publication, the ACTIVATE study met its primary endpoint, with 40% of patients randomized to PYRUKYND achieving a hemoglobin response, defined as a greater than or equal to 1.5 g/dL increase in hemoglobin concentration from baseline sustained at two or more scheduled assessments at Weeks 16, 20 and 24 during the fixed-dose period, compared to 0 patients randomized to placebo. Patients who received PYRUKYND had a significantly greater response than those who received placebo with respect to each secondary endpoint, including average change from baseline in hemoglobin level; average change from baseline in markers of hemolysis including indirect bilirubin, lactate dehydrogenase and haptoglobin levels; average change from baseline in markers of hematopoietic activity; and change from baseline in two PK deficiency-specific patient-reported outcome measures. The most common adverse events were nausea and headache. Adverse events of grade 3 or higher occurred in 10 patients who received PYRUKYND(R) and five patients who received placebo.

08:40 EDT Troika Media's Mission to support Diet Coke campaign in Great Britain - Troika Media Group announced that Mission, its London-based brand experience and communications company, will support Diet Coke on their 'Love What You Love' Campaign in Great Britain. TMG's Mission UK team is helping bring the Diet Coke 'Love What You Love' Above-the-Line Campaign to life, through a PR content series activation to generate coverage, awareness and ultimately, conversion. Mission has also implemented a robust influencer strategy to launch the fashion on-pack promotion through April - June, bringing to life the brand's partnership with London Fashion Week.

08:38 EDT Celsion, Medidata present findings of Phase Ib study of GEN-1 - Celsion (CLSN) and Medidata, a Dassault Systemes (DASTY) company, announced that they presented their findings on the use of a Synthetic Control Arm, SCA, in a completed Phase Ib dose-escalating study of GEN-1 in the neoadjuvant treatment of patients with Stage III/IV ovarian cancer at the Annual Meeting of the American Association for Cancer Research, AACR, in New Orleans, LA. In a poster presentation entitled "Phase IB trial efficacy estimates via a clinical trial synthetic control arm," Dr. Elizabeth Lamont presented the research team's findings that demonstrate how comparing patients from a single-arm trial can help enhance understanding of treatment effects in advance of randomized trials, inform drug development and trial design, and increase the scientific value of early phase trials. The Phase Ib OVATION I Study evaluated escalating doses of GEN-1 administered intraperitoneally in combination with three cycles of neoadjuvant chemotherapy prior to interval debulking surgery, followed by three cycles of NACT in the treatment of newly diagnosed patients with Stage III/IV ovarian cancer. GEN-1, designed using Celsion's proprietary TheraPlas platform technology, is an interleukin-12 DNA plasmid vector encased in a non-viral nanoparticle delivery system, which enables cell transfection followed by persistent, local secretion of the IL-12 protein.

08:37 EDT Sol-Gel Technologies announces commercial availability of TWYNEO - Sol-Gel Technologies announced that TWYNEO , a topical cream containing a fixed-dose combination of tretinoin, 0.1%, and benzoyl peroxide, 3% for the treatment of acne vulgaris in adults and pediatric patients nine years of age and older, is now available for purchase by consumers who obtain a prescription from their physician. TWYNEO Cream was approved by the U.S. Food and Drug Administration on July 27, 2021 and is being commercialized in the U.S. by Galderma. It is the first and only tretinoin and benzoyl peroxide 2-in-1 combination ever approved by FDA and has been proven to rapidly treat even moderate to severe facial acne.

08:36 EDT Ageagle Aerial Systems appoints Michael O'Sullivan as CCO - AgEagle Aerial Systems announced two key appointments to the Company's Executive Leadership Team as part of AgEagle's efforts to optimize skillsets and functionally align the management of its growing global operations. Reporting directly to AgEagle Chairman and CEO Barrett Mooney, Michael O'Sullivan's current role as Managing Director of the Company's operations in Lausanne, Switzerland, has been expanded with his appointment as AgEagle's Chief Commercial Officer. In addition, Edouard Rosset, Head of Research and Development and Head of Operations in Lausanne, has been promoted to Executive Vice President of Technology. O'Sullivan originally joined AgEagle in October 2021 upon the Company's acquisition of senseFly and was promptly appointed as Managing Director of the subsidiary. Prior to the acquisition of senseFly by AgEagle, Rosset served as Chief Technology Officer of senseFly where he led the design, engineering and development of senseFly's pioneering line of e-Bee-branded fixed wing drones.

08:35 EDT Coherus Biosciences, Junshi announce FDA granted ODD for toripalimab - Coherus BioSciences and Shanghai Junshi Biosciences announced that the United States Food and Drug Administration, FDA, has granted Orphan Drug Designation, ODD, for toripalimab, a PD-1 inhibitor, for the treatment of small cell lung cancer, SCLC. The JUPITER-08 study is an ongoing, randomized, double-blind, placebo-controlled, multi-center Phase 3 clinical trial evaluating PD-1 inhibitor toripalimab in combination with chemotherapy compared to placebo in combination with chemotherapy as the first-line treatment of extensive stage SCLC. Enrollment in this trial has been completed. The co-primary endpoints of the study are overall survival and progression free survival as assessed by the investigator. "Toripalimab in combination with chemotherapy has demonstrated robust antitumor immunity and survival benefit in multiple tumor types including in tumors with low PD-L1 expression. This differentiated clinical activity may result from toripalimab's unique binding epitope and internalization properties," said Dr. Theresa LaVallee, Chief Development Officer at Coherus. "SCLC patients have a particularly poor prognosis, and new and better treatment options are clearly needed for patients with this aggressive cancer. We are pleased to be working closely with our partner, Junshi Biosciences, to evaluate toripalimab in this underserved patient population and look forward to topline data from the pivotal first line SCLC clinical trial expected later this year."

08:34 EDT D.R. Horton to acquire Vidler Water Resources for $15.75 per share in cash - D.R. Horton (DHI) and Vidler Water Resources (VWTR) announced that the two companies have entered into a definitive merger agreement pursuant to which D.R. Horton will acquire Vidler for $15.75 per share in an all-cash transaction which represents a 19% premium to the 90-day volume-weighted average share price and a 39% premium to Vidler's book value of equity. Vidler owns a portfolio of premium water rights and other water-related assets in the southwestern United States in markets where D.R. Horton that require water for development, but face a lack of adequate supply. Post-closing, Vidler will operate as a separate operating division within D.R. Horton. Under the terms of the merger agreement, D.R. Horton, through its directly owned acquisition subsidiary, will commence a tender offer to acquire all outstanding shares of Vidler for $15.75 per share. Upon the successful completion of the tender offer, D.R. Horton's acquisition subsidiary will be merged into Vidler, and any remaining shares of Vidler will be canceled and converted into the right to receive the same consideration payable pursuant to the tender offer. Following completion of the merger, the common stock of Vidler will no longer be listed for trading on the Nasdaq. The total equity value of the transaction is approximately $291M and the transaction is expected to close during the second calendar quarter of 2022 subject to customary closing conditions.

08:32 EDT PTC Therapeutics updates EMA regulatory review of gene therapy program - PTC Therapeutics has completed the Scientific Advisory Group and Oral Explanation meetings for its gene therapy treatment for AADC deficiency - PTC-AADC - with the Committee for Advanced Therapies. The CAT is responsible for the scientific assessment of advanced therapies based on its expert member's assessment of the quality, safety and efficacy of the product. The CAT is scheduled to provide a draft opinion for adoption to the Committee for Medicinal Products for Human Use in May. If approved, PTC's AADC gene therapy would be the first marketed gene therapy directly infused into the brain. The AADC gene therapy Marketing Authorization Application is supported by the findings of three clinical studies conducted in Taiwan. While several diagnostic tests for AADC deficiency are available, the condition remains largely undiagnosed.

08:20 EDT Midatech Pharma receives non-compliance notice from Nasdaq - Midatech Pharma announces that it received written notification from The NASDAQ Stock Market, dated 13 April 2022, stating that the Company is not in compliance with the minimum bid price requirement set forth in NASDAQ's rules for continued listing on The NASDAQ Capital Market. NASDAQ Listing Rule 5550(a)(2) requires listed securities to maintain a minimum bid price of $1.00 per share, and Listing Rule 5810(c)(3)(A) provides that a failure to meet the minimum bid price requirement exists if the deficiency continues for a period of 30 consecutive business days. Based on the closing bid price of the Company's American Depositary Shares, each representing five ordinary shares of the Company, for the 30 consecutive business days beginning 2 March 2022, the Company no longer meets the minimum bid price requirement. The Notification Letter has no immediate effect on the listing of the Depositary Shares, and they will continue to trade on The NASDAQ Capital Market under the symbol "MTP." In accordance with NASDAQ Listing Rule 5810(c)(3)(A), the Company has a grace period of 180 calendar days, or until 10 October 2022, to regain compliance with the minimum bid price requirement. To regain compliance, the closing bid price of the Depositary Shares must meet or exceed $1.00 per share for at least 10 consecutive business days during the Compliance Period. If the Depositary Shares do not regain compliance with the minimum bid price requirement during the Compliance Period, the Company may be eligible for an additional grace period of 180 calendar days provided that the Company satisfies NASDAQ's initial listing standards for listing on The NASDAQ Capital Market, other than the minimum bid price requirement, and provides written notice to NASDAQ of its intention to cure the delinquency during the second grace period. If the Company does not regain compliance during the initial grace period and is not eligible for an additional grace period, NASDAQ will provide written notice that the Depositary Shares are subject to delisting from The NASDAQ Capital Market. In that event, the Company may appeal such determination to a hearing panel. The Company intends to monitor the bid price of its Depositary Shares during the Compliance Period and will consider taking such actions as may be necessary and appropriate to achieve compliance with continued listing requirements prior to the expiration of all available grace periods. The Company's business operations are not affected by the receipt of the Notification Letter. The Company's ordinary shares are listed on the AIM Market of the London Stock Exchange, and the Notification Letter does not affect the Company's compliance status with such listing.

08:17 EDT Middlefield Banking appoints Alfred Thompson as CCO, Courtney Erminio as CRO - The Middlefield Banking Company announced the Company has promoted AlfredThompson Jr. to EVP/Chief Credit Officer and Courtney Erminio to EVP/Chief Risk Officer. As EVP/CCO, Mr. Thompson will be responsible for leading the Company's credit administration and loan administration programs. Since joining Middlefield in 1996 as an Assistant VP/Lender, Mr. Thompson has held a variety of positions of increased responsibility. Most recently, Mr. Thompson held the position of SVP/Credit Administration - Special Assets. As EVP/CRO, Ms. Erminio will be responsible for leading the Company's risk, audit, and compliance programs. She joined Middlefield in 2010 as SVP/Risk Officer.

08:16 EDT SAIC announces $64M contract extension with County of Orange, California - Science Applications International announced that the County of Orange, California awarded the company a contract extension to continue to provide information technology managed services and solutions to agencies and departments within the county. As part of the contract, SAIC's services support the county's data center, desktop, service desk, applications, networks, voice environment and security operations. "This contract extension is a testament to our success in delivering high-performance IT managed services to the County of Orange in partnership with our customer," said Bob Genter, president, Defense and Civilian Sector at SAIC. "Our history over the eight-year period includes county customer satisfaction surveys that consistently rate our performance as highly satisfied. We are absolutely committed to helping the county continue to reduce costs, improve operational efficiencies, and improve services to residents." The firm-fixed-price contract extension has a base period of performance of 24 months, valued at approximately $64M, followed by two one-year option periods. SAIC will primarily perform work under this contract in Santa Ana, California.

08:14 EDT Sera Labs products available at Walmart, Bed Bath & Beyond, CVS, Target - Sera Labs announced its Seratopical Revolution skincare line will be sold at select Walmart (WMT) Stores, as well as CVS (CVS), and Bed Bath & Beyond (BBBY) stores. Sera Labs also has garnered placement for its oral thin film strip, Nutri-Strips on shelves at CVS and at Target.com (TGT). The Nutri-Strip technology is proprietary to Sera Labs and is the result of years of research and more than 25 patents by CURE Pharmaceutical.

08:12 EDT ViaSat partners with Slovakia to donate wi-fi to Ukrainian refugees - Viasat and the Koice region, Slovakia, have partnered to provide free high-speed internet to Ukrainian refugees in Eastern Slovakia using Viasat's satellite-enabled Community Internet system. Viasat Community Internet sites are being installed across Eastern Slovakia in areas of greatest need for refugee connectivity. The Viasat Community Internet service implements a public Wi-Fi hotspot connected and enabled by a Viasat satellite to deliver free high-speed internet service to these refugee communities that previously had little or no internet connectivity.

08:11 EDT Gentherm releases 2021 Sustainability Report - Gentherm published its 2021 Sustainability Report. The 2021 Sustainability Report highlights Gentherm's key areas of focus: People, Planet, and Places, and provides updates on previously established environmental performance metrics. In addition, Gentherm has announced it is working to develop a net-zero carbon position. "We know being responsible global citizens means we must put sustainability at the core of our business. To do this we are developing products that make a positive impact on our environment, actively engaging in the communities where we do business, and working to build strong employee engagement," said Phil Eyler, President and CEO of Gentherm. "We believe our current and future technologies play an important role in leading the development of sustainable, safe, and intelligent solutions for electric vehicles and the future of mobility."

08:09 EDT CSW Industrials board increases quarterly dividend 13% to 17c per share - The Board of Directors of CSW Industrials declared a regular quarterly cash dividend of 17c per share. This represents an increase of 2c per share, or approximately 13%, as compared to the declared dividend in the prior quarter. The dividend is payable on May 13, 2022, to shareholders of record as of the close of business on April 29, 2022. "We are pleased to announce another increase in our quarterly dividend and to provide an update on our share repurchase program, which together demonstrate our ongoing commitment to disciplined capital allocation. Over the past four years, we have returned $121.1 million in cash to our shareholders, while also growing organically and through acquisitions," said Joseph Armes, CSW Industrials Chairman, President, and Chief Executive Officer.

08:09 EDT Global Crossing Airlines to celebrate first A321 P2F conversion - Global Crossing Airlines Group will celebrate a key milestone for its first A321 P2F aircraft by ST Engineering with a door cutting ceremony that takes place this morning. The freighter aircraft is currently undergoing conversion at ST Engineering's airframe facility in San Antonio. GlobalX and ST Engineering had in 2021 signed an LOI to lease up to five A321 P2F. The first aircraft is expected to be delivered in Q3 2022. In addition to leasing freighter aircraft, GlobalX will also use the engineering and maintenance services provided by ST Engineering to support the operation of its passenger and freighter aircraft.

08:08 EDT Enphase Energy expands battery storage in Iowa - Enphase Energy announced that installers of Enphase products in Iowa have seen growing deployments of the Enphase Energy System powered by IQ Microinverters and IQ Batteries. Iowa homeowners can now also choose to install Enphase's IQ8 Microinverters. IQ8-based systems can provide Sunlight Backup during an outage, even without a battery. Enphase delivers a safer solar-plus-battery solution which does not expose installers or homeowners to high-voltage DC. Enphase IQ Batteries feature Lithium Iron Phosphate battery chemistry, which provides a long cycle life and safer operation through excellent thermal stability. "In Iowa, more homeowners than ever are investing in a backup power source to stay more secure and comfortable during grid outages," said Dave Ranhoff, chief commercial officer at Enphase Energy. "With IQ8 Microinverters and the IQ Batteries, homeowners get the reliable energy resilience they are looking for, plus they can better manage their energy bills and reduce their carbon footprint."

08:07 EDT Bowlero announces redemption of all outstanding warrants - Bowlero announced that it will redeem all of its publicly traded and privately held warrants to purchase shares of Bowlero's Class A common stock, par value $0.0001 per share, that remain outstanding at 5:00 p.m. New York City time on May 16, 2022, for a redemption price of $0.10 per warrant. Bowlero has directed its warrant agent, Continental Stock Transfer & Trust Company, to deliver a notice of redemption to the registered holders of outstanding warrants pursuant to the Warrant Agreement, dated as of March 2, 2021, by and between Bowlero and the Warrant Agent. Under the Warrant Agreement, Bowlero is entitled to redeem its public warrants at a redemption price of $0.10 per warrant if the last sale price of the Common Stock equals or exceeds $10.00 per share on the trading day before the Company sends the notice of redemption, among other conditions. The stock price condition was satisfied on April 13, 2022, the day before the Notice of Redemption is being sent to warrant holders. Warrants to purchase Common Stock that were issued under the Warrant Agreement in a private placement simultaneously with Bowlero's initial public offering and still held by the initial holders thereof or their permitted transferees are also subject to the Notice of Redemption. Warrant holders may continue to exercise their warrants to purchase shares of Common Stock until immediately before 5:00 p.m. New York City time on the Redemption Date. Payment upon exercise of the warrants may be made either in cash, at an exercise price of $11.50 per share of Common Stock or on a "cashless" basis in which the exercising holder will receive a number of shares of Common Stock determined under the Warrant Agreement and based on the Redemption Date and the Redemption Fair Market Value. The "Redemption Fair Market Value" is based on the volume weighted average price per share of Common Stock for the 10 trading days immediately following on the third trading day prior to the date on which the notice of redemption is sent. In accordance with the Warrant Agreement, Bowlero will provide warrant holders with the Redemption Fair Market Value no later than one business day after the 10-trading-day period ends. In no event will the number of shares of Common Stock issued in a cashless exercise exceed 0.361 shares per warrant exercised. If a holder of warrants would be entitled to receive a fractional share of stock as a result of warrants exercised at one time, the number of shares the holder will be entitled to receive will be rounded down to the nearest whole number of shares. Holders wishing to exercise their warrants should follow the procedures described in the Notice of Redemption and the Election to Exercise form included with the notice. Holders of warrants held in "street name" should immediately contact their brokers to determine exercise procedures. Since the act of exercising is voluntary, holders must instruct their brokers to submit the warrants for exercise. Any outstanding Bowlero warrants that remain unexercised at 5:00 p.m. New York City time on the Redemption Date will be void and no longer exercisable, except to receive the Redemption Price or as otherwise described in the Notice of Redemption.

08:06 EDT Moleculin Biotech announces corporate rebranding, launch of new website - Moleculin Biotech announced the launch its new corporate branding and website www.moleculin.com. "As we drive clinical development across our broad portfolio of drug candidates, expand our growing body of clinical data and build value among all stakeholders, we believed it was an important step to refresh our corporate branding identity and website to align with the true potential and vision we have for Moleculin. We are wholeheartedly committed to potentially solving some of the toughest challenges and importantly, bringing better treatments to patients where there remains unmet medical need. The work completed and data demonstrated to-date bolsters our confidence as we believe we can successfully execute on a number of key clinical and regulatory milestones that will be instrumental in establishing a clear path to approval and commercialization of Annamycin. I am excited for this evolution of Moleculin and to take another step forward towards the future of this exciting company," commented Walter Klemp, Chairman and CEO of Moleculin.

08:06 EDT Sonim sells $17.5M in shares to AJP Holding, appoints Peter Liu as CEO - Sonim has entered into a subscription agreement with U.S.-based AJP Holding whereby AJP will purchase a total of 20.8 million shares at a price of 84c per share and an aggregate purchase price of $17.5M. Upon completion of the transaction, which is subject to stockholder approval and other customary closing conditions, AJP will own approximately 52% of Sonim's post-transaction outstanding capital stock based on an estimated 19.3 million shares outstanding prior to the transaction. The agreement with AJP will also include a transition of the management team as Sonim aims to expand into the larger and faster growing semi-rugged and industrial 5G markets. Peter Liu, who has served as Executive VP for Global Operations and Engineering since 2010, has been appointed CEO, effective April 14. Liu is part of the investment group at AJP and leading the strategic development of Sonim's expanded market focus. The board of directors of Sonim has approved the transaction, which will involve two closings. The first closing, including the common stock purchase of approximately 14.9 million shares of Common Stock for an aggregate purchase price of $12.5M, is subject to customary closing conditions. The second closing, for approximately 5.9 million shares of Common Stock for an aggregate purchase price of $5.0M, is expected to occur on or around August 1, subject to the occurrence of the first closing.

08:05 EDT Proterra introduces ZX5 electric transit bus with 738 kWh of energy - Proterra announced that it is increasing the amount of energy onboard its purpose-built ZX5 electric transit bus - delivering more battery storage to help transit agencies scale zero-emission bus fleets with electric vehicle technology. Starting in 2023, the 40-foot Proterra ZX5 Max electric transit bus can be equipped with up to 738 kilowatt hours of onboard energy. Through this enhancement, Proterra transit buses now feature the most energy storage of any 40-foot electric bus available in the North American market. With 738 kWh of battery energy storage, the ZX5 Max can deliver more than 300 miles of drive range on a single charge, depending on route conditions, configuration and operation. In addition, the 35-foot and 40-foot ZX5+ electric bus models can be equipped with up to 492 kWh of onboard energy for routes with less demanding range requirements.

08:05 EDT RMR Group raises quarterly dividend 5.3% to 40c per share - The RMR Group announced it has raised its regular quarterly cash dividend on its shares of Class A Common Stock and Class B-1 Common Stock to 40c per share for the quarter ended March 31, representing a 5.3% increase over last quarter's cash dividend of 38c per share. This distribution will be paid to RMR's shareholders of record as of the close of business on April 25 and distributed on or about May 19.

08:04 EDT Bionano Genomics issued two U.S. patents for uses of nanochannel arrays - Bionano Genomics announced that the United States Patent and Trademark Office issued two new US Patents, No. 11,291,999 and No. 11,292,713 on April 5, 2022. The '999 patent, titled "Photocleavage method and apparatus to clean fluidic devices," claims a novel apparatus and method for using a light source to minimize aggregation of biopolymers in or around a nanochannel. This technology is used by Bionano to enable multiple cycles of DNA loading, imaging, clearing and reloading, making it important to the performance of Bionano's nanochannel arrays. This patent family also includes issued patents in Japan and China. The '713 patent, titled "Integrated analysis devices analysis techniques," expands upon the company's existing patent protection for its optical genome mapping technology. The patent claims methods of identifying genomic sequences or structural genomic variants by linearizing target DNA molecules through a series of nanochannels within a nanochannel array and detecting of specific signals that correlate with a property of the target DNAs. Bionano's intellectual property portfolio includes multiple patents covering its core technology issued both in the US and internationally. Additionally, Bionano's portfolio includes patents directed to methods of fabricating nanochannel devices, as well as other technologies for sample processing and analysis related workflows.

08:02 EDT Galectin Therapeutics reports outcome of DSMB meeting for NAVIGATE - Galectin Therapeutics reported the positive outcome of its first data and safety monitoring board, DSMB, meeting for NAVIGATE, its phase 2b/3 study of belapectin in patients with liver cirrhosis caused by non-alcoholic steatohepatitis, NASH. NAVIGATE is the first study of its kind and is a global effort that recruits patients over 15 countries and five continents. The study main efficacy objective is the primary prevention of esophageal varices. Dr. Pol Boudes, M.D., Chief Medical Officer of Galectin Therapeutics, said: "The positive recommendation of the DSMB meeting is a very important milestone for Galectin Therapeutics and for patients affected by liver cirrhosis due to NASH. This recommendation confirms that belapectin appears safe and well tolerated to date. Such a safety profile is an essential asset for a candidate drug designed for cirrhotic patients, as they are fragile, may need adjustment or interruption of common drug treatments, and are also frequently immune-compromised. Currently patients with decompensated liver disease, have no other hope than to receive a liver transplantation. A transplantation is a complex and expensive procedure, requiring life-long immunosuppression and specialized follow-up, and is further affected by a global shortage of organs. With the NASH epidemy and the resulting increasing number of patients that will suffer from liver cirrhosis, the liver organ shortage is only going to get worse, further highlighting the urgent need for new treatments. This successful DSMB meeting furthers our objective of advancing the belapectin program and bringing hope to our patients. I also want to take this opportunity to thank our investigators and their teams for participating in this innovative study." Dr. Boudes added: "The first patients in NAVIGATE have now reached their 18-month visit and have elected to continue into the extension phase of the phase 3 part of NAVIGATE. This is an additional significant milestone for the belapectin development program as we are now starting to collect follow-up data beyond a year and a half of treatment to further inform the benefit risk of belapectin in cirrhotic patients."

08:01 EDT Unisys appoints Debra McCann as CFO, Mike Thomson as COO - Unisys appointed Debra McCann as Executive VP and CFO. McCann's appointment is effective May 2. McCann joins Unisys from Dun & Bradstreet , where she most recently served as treasurer and senior vice president of investor relations and corporate FP&A. Prior to joining D&B in 2009, she was senior director of FP&A, risk management and procurement at Cegedim. In November 2021 the company announced Thomson's appointment as president and COO, effective upon the hiring of a new CFO. Thomson, who joined Unisys in December 2015 as corporate controller and principal accounting officer and was named CFO in September 2019, will continue to report to CEO Altabef in his new role.

07:53 EDT Goldman Sachs reports Q1 FICC revenues $4.72B, up 21% y/y

07:52 EDT Goldman Sachs CEO: Q1 was 'turbulent' quarter - Goldman Sachs Chairman and CEO David Solomon said: "It was a turbulent quarter dominated by the devastating invasion of Ukraine. The rapidly evolving market environment had a significant effect on client activity as risk intermediation came to the fore and equity issuance came to a near standstill. Despite the environment, our results in the quarter show we continued to effectively support our clients and I am encouraged that our more resilient and diversified franchise can generate solid returns in uncertain markets."

07:48 EDT Adagio Therapeutics pauses submission of EUA request for adintrevimab - Adagio Therapeutics announced preliminary clinical results from its Phase 2/3 clinical trials of adintrevimab and is providing an update on the anticipated timing for its Emergency Use Authorization request for adintrevimab for the prevention and treatment of COVID-19. The Omicron BA.2 variant, which has shown reduced in vitro susceptibility to monoclonal antibodies, has recently emerged as the current predominant variant of SARS-CoV-2 in the U.S. Adintrevimab, which has demonstrated broadly neutralizing activity in vitro against SARS-CoV-2 variants of concern including Alpha, Beta, Delta, Delta Plus, Gamma and Omicron BA.1, has markedly reduced neutralization activity in vitro against the Omicron BA.2 variant. Based on feedback from the U.S. Food and Drug Administration regarding adintrevimab's lack of neutralizing activity against the BA.2 variant, Adagio is pausing the submission of an EUA request. Adagio intends to continue engaging with the FDA and monitor the evolution of SARS-CoV-2 and the in vitro activity of adintrevimab against predominant variants in the U.S. to determine the optimal timing for its planned EUA request. Adagio is committed to advancing adintrevimab as a potential future therapeutic option in anticipation of the emergence of new variants. The company is also conducting an ongoing Phase 1 trial evaluating pharmacokinetics and safety of higher doses of adintrevimab in healthy volunteers and is continuing its antibody research efforts, including efforts to modify adintrevimab to improve binding to the Omicron BA.1 and BA.2 subvariants. Adagio is on-track to have more than one million doses of adintrevimab secured in 2022, in preparation of its potential utility as a prophylaxis and treatment option for COVID-19 in the future.

07:46 EDT Jacobs selected to design Changi NEWater Factory 3 in Singapore - Jacobs was selected by PUB, Singapore's National Water Agency, to design and supervise construction and commissioning of the Changi NEWater Factory 3, the third NEWater plant to be located at the Changi Water Reclamation Plant. CNF3 will be one of the first reclamation plants globally to use Membrane Bioreactor filtrate to feed reverse osmosis membranes. CNF3 will incorporate water technology firm ROTEC's proprietary reverse osmosis flow reversal technology into the design of the RO system to increase the recovery rate of NEWater from 75% to 90%. Design of CNF3 is underway and construction is expected to begin later in 2022, with the plant expected to be completed in 2024.

07:45 EDT OverActive Media signs VALORANT European player roster - OverActive Media is pleased to announce its entry into the growing competitive VALORANT scene with the signing of a top European player roster. Launched in June 2020 by Riot Games, VALORANT reached 14 million monthly active PC players and half a billion games played in its first year. They also developed the VALORANT Champions Tour, Riot's first official tournament circuit for the game, to support the demand for various levels of competition. As of March 2022, VALORANT is one of the top five most-watched games on Twitch. OverActive Media's VALORANT team roster, brand and location will be revealed later in April.

07:45 EDT Valneva SE (ADS) trading halted, news pending

07:43 EDT Dirtt Environmental announces ISS recommends against full board change - DIRTT Environmental Solutions announced that 22NW Fund attempt to take over its board of directors is opposed by the leading independent proxy advisor Institutional Shareholder Services, ISS, which has recommended AGAINST a full Board change. In its report, ISS stated that 22NW "has not presented a clear go-forward plan," that it was "vague on details," and "has not met the threshold" for a full Board change. ISS also stated 22NW's slate lacked "racial diversity and there would only be one female on the board," highlighting 22NW's poor focus on corporate governance. DIRTT "recognizes the value of strategic and deliberate Board refreshment, balanced with historical continuity given the unique nature of DIRTT's business," the company said. DIRTT said that its efforts were recognized by ISS, who stated in its report that "The board's refreshment over the last few years is apparent, with four directors with one year of tenure and a new nominee at this meeting..." The Board is also pleased that ISS recognized its call for operational change within the business. These changes have been well underway and has gathered momentum under the guidance of the Board and under the leadership of interim CEO Todd Lillibridge. A wholesale change of the Board could reverse this progress and create significant risk. ISS agreed with having additional directors as first proposed by DIRTT, and following their recommendation, the Board is now prepared to include English as well as Kenneth Sanders and Mary Garden. ISS recommended a vote in favour of the change of the Company's name, rejecting the rationale of 22NW by stating that "empirical evidence suggests that changing a company's name can impact its value. Name changes should be evaluated on a case-by-case basis. In this case, there is little danger that sales would suffer due to a loss of name recognition and associated goodwill."

07:41 EDT Scientific Games extends contract with interactive entertainment group Entain - Scientific Games Corporation, doing business as Light & Wonder has extended its existing agreement with global sports betting, gaming and interactive entertainment group Entain through to 2030. The original agreement signed with Entain in 2018 was a landmark deal for the Company and the largest contract to date for Light & Wonder's UK gaming business. This extension has built on this successful relationship and is testament to the ongoing success of the Company's UK retail server-based gaming solution and strength of the long-term partnership with Entain. Light & Wonder will continue to supply over 10,000 terminals to Entain's licensed betting offices LBO through their Coral and Ladbrokes retail shops. The Company will also provide industry-leading game titles from its global game portfolio as well as titles from its Manchester Studio, which has recently launched successful key titles including Lord of The Rings and 777 High & Mighty. Additionally, the Company's leading content aggregation platform provides Entain access to an extensive library of over 3,000 titles available from the world's leading studios, complemented by cutting-edge player features including responsible gaming tools. "Our stores provide an engaging and differentiated experience for our customers. Light & Wonder enhances that with the industry's best gaming machines backed up by a great range of leading games, service infrastructure and support," said Andy Hicks, Retail MD UK & Ireland at Entain.

07:39 EDT Milestone Scientific expands its dental strategy with recent agreements - Milestone Scientific announced it has expanded its dental strategy, entering the growing dental implant and dental service organization markets, along with new educational initiatives. Recent Agreements: Added Keystone Dental Group as a strategic channel partner for the STA Single Tooth Anesthesia System; Established a partnership with American Independent Dental Alliance, America's premier DSO network of private practice dentists, as part of a broader initiative to target the DSO market; Enhanced educational activities through an agreement with Esthetic Professionals. Arjan Haverhals, CEO of Milestone Scientific Inc. commented, "We are delighted to announce a series of key initiatives to expand domestic distribution of the STA Single Tooth Anesthesia system. Keystone Dental Group is an ideal strategic channel partner given their dedicated sales force and broad reach across the U.S. Implant dentistry is a natural fit for the STA Single Tooth Anesthesia system, since it allows for localized anesthesia across a wide range of dental procedures. Through the use of our STA Single Tooth Anesthesia system, implant dentistry can be performed without the discomfort or potential risks and complications that could occur when numbing an entire quadrant of the patient's mouth. Keystone Dental Group has a proven track record of introducing new products, including specialized instruments that require hands on training and support."

07:36 EDT Stellantis, Qualcomm collaborate to power vehicle platforms with Snapdragon - Stellantis (STLA) and Qualcomm Technologies (QCOM) announced a multi-year technology collaboration to utilize the latest Snapdragon Digital Chassis advancements to deliver intelligent, customizable and immersive in-vehicle experiences vehicles across Stellantis' 14 automotive brands beginning in 2024. This agreement will facilitate Stellantis' plan to merge all software domains into High Performance Computers, leveraging the high-performance, low-power Snapdragon Automotive Platforms across all major vehicle domains as well as contribute to securing Stellantis' supply chain on strategic components. "Our technology collaboration with Qualcomm Technologies is another example of how we are identifying industry leaders to work alongside our passionate and talented internal teams as we transform our vehicles through a software-defined approach. This will ultimately better meet the needs of our customers' lifestyles through safe, personalized, and always-connected features," said Carlos Tavares, Stellantis CEO. "Qualcomm Technologies' broad experience in automotive and scale as a semiconductor leader will enable us to vertically integrate key elements of our new platforms and more closely manage the complete electronics supply chain to provide access to the best technologies, enable the fulfillment of Stellantis' volume potential and achieve our Dare Forward 2030 ambition."

07:35 EDT Biohaven Pharmaceutical's Nurtec expands coverage, adds lactation label data - Biohaven Pharmaceutical announced two updates regarding Nurtec ODT - rimegepant -, the only FDA-approved medication to both treat and prevent migraine attacks in adults. Biohaven has secured additional commercial insurance coverage for Nurtec ODT starting in April that expands the total number of commercial lives covered to 96% or approximately 255 million people via all channels. The FDA has approved a label amendment of the Nurtec ODT Prescribing and Patient Information to include clinical lactation data in the Use in Specific Populations section as it relates to women who are breastfeeding. The label amendment was approved based on data from a Phase 1 study evaluating the excretion of a single dose of rimegepant 75 mg in the human milk of healthy lactating women, recently published in the peer-reviewed journal, Breastfeeding Medicine.

07:30 EDT Great Panther Mining reports Q1 production of 17,913 gold equivalent ounces - Great Panther Mining reports production results for the three months ended March 31, from its two wholly-owned operating mines, Tucano in Brazil and Topia in Mexico. First quarter 2022 production highlights: Consolidated metal production of 17,913 gold equivalent ounces, inclusive of 14,319 gold ounces and 173,698 silver ounces. Total gold production at Tucano of 14,037 Au oz. Total silver equivalent production at Topia of 290,694 silver equivalent ounces.

07:26 EDT Musk: 'Not playing the back-and-forth game' with Twitter offer - Elon Musk sent a text message on Wednesday evening to Twitter chairman Bret Taylor. The text read: "As I indicated this weekend, I believe that the company should be private to go through the changes that need to be made. After the past several days of thinking this over, I have decided I want to acquire the company and take it private. I am going to send you an offer letter tonight, it will be public in the morning. Are you available to chat? 1. Best and Final: a. I am not playing the back-and-forth game. b. I have moved straight to the end. c. It's a high price and your shareholders will love it. d. If the deal doesn't work, given that I don't have confidence in management nor do I believe I can drive the necessary change in the public market, I would need to reconsider my position as a shareholder. i. This is not a threat, it's simply not a good investment without the changes that need to be made.ii. And those changes won't happen without taking the company private. 2. My advisors and my team are available after you get the letter to answer any questions a. There will be more detail in our public filings. After you receive the letter and review the public filings, your team can call my family office with any questions."

07:18 EDT Daniel Lau acquires additional priority units of Noranda Income Fund - Daniel Lau announced that on April 13, 2022, in his capacity as an Advising Representative for Qwest Investment Fund Management, on behalf of the LM Asset Fund Limited Partnership, he acquired control and direction over 800,000 priority units of Noranda Income Fund at a price of $1.65 per Unit. The acquired Units represent approximately 2.13% of the issued and outstanding Units of Noranda. As a result of the acquisition and together with securities previously held personally by Daniel Lau, he now owns and/or exercises control and direction over 4,353,700 Units which represent approximately 11.61% of the issued and outstanding Units of Noranda. Prior to the acquisition, Daniel Lau had beneficial ownership of 114,000 Units and had control and direction over 59,700 Units held by LM Asset Management and 3,380,000 Units held by LM Asset Fund Limited Partnership, in his capacity as Advising Representative for Qwest Investment Fund Management. Following the acquisition, Daniel Lau has beneficial ownership of 114,000 Units and has control and direction over 59,700 Units held by LM Asset Management, and 4,180,000 Units held by LM Asset Fund Limited Partnership, in his capacity as Advising Representative for Qwest Investment Fund Management. Daniel Lau, in his capacity as Advising Representative for Qwest Investment Fund Management Ltd., acquired the Units for passive investment purposes. Daniel Lau and/or its joint actors may, from time to time, directly or indirectly, acquire or sell securities of Noranda.

07:16 EDT Unicycive announces KOL event highlighting kidney disease treatments - Unicycive Therapeutics announced that there will be a Key Opinion Leader Event discussing "Novel Treatments in Kidney Disease" with leading physician and thought leader, Glenn Chertow, M.D., MPH, Professor of Medicine at Stanford University School of Medicine and, by courtesy, Professor of Epidemiology and Population Health. Dr. Chertow also serves as a member of Unicycive Therapeutics' Scientific Advisory Board. The event will be moderated by Elemer Piros, Ph.D., Senior Biotechnology Analyst at ROTH Capital, who covers Unicycive Therapeutics. Date/Time:April 20, 2022 from 12:00 pm - 1:00 pm.

07:14 EDT Wellbeing Digital CEO unveils global, comprehensive strategy - Wellbeing Digital Sciences is pleased to announce the start of a global and comprehensive strategy, mission and vision for Wellbeing by its recently appointed CEO, Najla Guthrie. The plan involves expanding the Company's primary focus and re-engineering of psychedelic treatment services offered throughout North America. Wellbeing will work to establish next-generation mental health clinics, contemporize existing clinic facilities and launch best-in-class adjunct programs to improve patient treatment outcomes. With expertise spanning several areas of mental health treatments as well as contract research, Wellbeing will facilitate the development and clinical adoption of novel mental health treatments. The comprehensive plan is expected to bolster Wellbeing's goal of becoming the healthcare model of choice in North America for the treatment of mental illnesses. The Company's pursuits are to be centred around the following values and mission: To enrich lives through mental healthcare services; To transform lives, improve patient experience, through a contemporary, global and comprehensive mental healthcare model of service; To equip clinicians with new tools to complement existing pharmacotherapeutic approaches; To re-conceptualize the way mental health services are delivered to the community; and To make a positive impact on the lives of patients, create an active network of collaborating mental heath experts, foster future innovation, and re-engineer the way present-day mental healthcare services are delivered to create change and improve patient outcomes. By the age of 40, approximately 50% of the population will suffer or have suffered from a mental health illness. Accordingly, the Company's management team deems it to be more important now than ever to find innovative and effective solutions to address mental illness issues. Wellbeing aims to conduct contract research and provide novel technology-enabled solutions backed by scientific evidence, to clinics around North America, by using digital therapeutics to complement physical therapy, psychotherapy, pain management and psychedelic-based treatments. The Company also intends to create a contemporary network of collaborating clinicians to bring forth the best mental health services under its re-conceptualized plan.

07:13 EDT Delta 9 Cannabis enters into agreement with Manitoba - Delta 9 Cannabis announces that, through its new wholly owned subsidiary Delta 9 Logistics, it has entered into a Limited Cannabis Distribution Agreement with Manitoba Liquor and Lotteries, MBLL, and the Company anticipates becoming one of Manitoba's first licensed cannabis distributors. Under the Distribution Agreement, Delta 9 intends to work with authorized cannabis suppliers to provide cross-docking and distribution services, fulfilling delivery of orders to licensed cannabis retailers within the province of Manitoba. "We see Delta 9's entry into the distribution services space to be the logical next step in the Company's vertical integration strategy," said John Arbuthnot, CEO of Delta 9. "Delta 9's existing relationships with the Canadian cannabis industry's leading suppliers and centralized warehouse presence in Winnipeg make us the ideal provider of these market services."

07:12 EDT Else Nutrition signs new agreement to expand its products with Rouses Markets - Else Nutrition announced that following the successful launch and performance of Else Toddler Nutrition, Rouses Markets has added two additional products - Else Plant-Based Kids Shakes, in chocolate and vanilla flavors. The products are now available at all 65 Rouses' locations and extend the company's shelf presence by offering its clean label-certified and whole Plant-Based nutrition into the kids' segment.

07:10 EDT SEE, ExxonMobil, and Ahold Delhaize team on circularity initiative - SEE (SEE), ExxonMobil (XOM), and Ahold Delhaize USA announced their collaboration on an advanced recycling initiative, the first of its kind in the U.S. The project recycles flexible plastics from the food supply chain and remakes them into new, certified circular food-grade packaging. The initiative is expected to begin this summer and scale over time. "We're proud to work with SEE and ExxonMobil on this collaboration, which has the potential to radically change the way retailers and manufacturers leverage food-grade recycled plastics as a key means of keeping plastics out of landfills," said Brittni Furrow, VP, Health & Sustainability, Ahold Delhaize USA. "We're eager to learn from this work and apply the learnings to advance our own plastics ambitions, but also advance these efforts broadly, helping to ensure a better tomorrow for our planet." A critical challenge facing the food industry is driving a circular economy for plastics using packaging materials that have strict hygiene and performance requirements for food protection and distribution. Recovering these essential packaging materials requires innovative recycling solutions beyond traditional mechanical recycling. The collaboration between SEE, ExxonMobil, and Ahold Delhaize USA will help increase the use of recycled content by validating the technical and economic viability of a certified circular system based on advanced recycling technology and mass balance attribution. Flexible plastics will be designed to be collected, recycled, and repurposed into new food packaging. The project will help keep used flexible plastics out of landfills, increase the number of times essential plastics can be recycled, and ensure the safety and quality of packaged foods.

07:08 EDT Luckin Coffee files 2021 annual report on Form 20-F - Luckin Coffee announced that it has filed its annual report on Form 20-F for the fiscal year ended December 31, 2021 with the U.S. Securities and Exchange Commission.

07:08 EDT Guardforce regains compliance with Nasdaq - Guardforce announced that it has received notice from Nasdaq informing Guardforce AI that it has regained compliance with the minimum bid price requirement under Nasdaq listing rule 5550 for continued listing on Nasdaq. Consequently, Guardforce AI is now in compliance with all applicable listing standards and its ordinary share will continue to be listed on Nasdaq.

07:05 EDT Oncolytics' pelareorep shows anti-cancer potential in publication - Oncolytics announced the publication of preclinical data demonstrating the synergistic anti-cancer activity of pelareorep combined with chimeric antigen receptor (CAR) T cell therapy in solid tumors. Key data and conclusions from the paper include: the persistence and anti-cancer activity of CAR T cells improved drastically when loaded with pelareorep; compared to either treatment alone, treatment with CAR/Pela therapy led to statistically significant survival benefits in murine skin and brain cancer models; CAR/Pela therapy followed by a pelareorep boost led to enhanced efficacy in murine skin and brain cancer models and tumor cures in greater than80% of treated mice in each model; loading CAR T cells with pelareoep led to improved cancer cell targeting and prevented antigen escape in vivo by generating CAR T cells with dual specificity that target their designed antigen and the native T cell receptor antigen. These results indicate that CAR/Pela therapy may provide longer-lasting therapeutic benefits compared to treatment with CAR T cells alone.

07:04 EDT Main Street originated $226.6M in new commitments in Q1 - Main Street Capital is pleased to announce the following recent activity in its private loan portfolio. During the first quarter of 2022, Main Street originated approximately $226.6M in new commitments in its private loan portfolio across six new and two existing borrowers and funded total investments across its private loan portfolio with a cost basis totaling approximately $201.5M.

07:01 EDT Regeneron: FDA extends review of BLA for REGEN-COV to treat COVID-19 - Regeneron announced that the U.S. FDA has extended by three months its review of the Biologics License Application for REGEN-COV to treat COVID-19 in non-hospitalized patients and as prophylaxis in certain individuals. The extension is due to ongoing discussions with the FDA on pre-exposure prophylactic use, for which Regeneron has submitted additional data from its completed prophylaxis trial that the FDA has accepted for review. The FDA considers the submission of these additional data to be a Major Amendment to the BLA and has provided a new target action date of July 13, 2022. The FDA has not requested any new studies to complete its review of the current BLA at this time.

06:59 EDT Sandoz launches generic brimonidine tartrate/timolol maleate eyedrop in U.S. - Sandoz, a Novartis (NVS) division, announced the U.S. launch of its generic combination eyedrop brimonidine tartrate/timolol maleate ophthalmic solution 0.2%/0.5%, an AB-rated generic equivalent to AbbVie's (ABBV) COMBIGAN, to lower eye pressure in patients with ocular hypertension. This prescription eyedrop is immediately available to patients via retail pharmacies, the company noted.

06:51 EDT U.S. Bancorp reports Q1 average total deposits growth of 6.5% year-over-year - In Q1: Average total loans and earning assets growth of 6.5% year-overyear. Average total loans grew 3.4% on a linked quarter basis. Average total deposits growth of 6.5% year-over-year and 1.0% linked quarter. Net charge-off ratio of 0.21% in 1Q22 compared with 0.17% in 4Q21 and 0.31% in 1Q21. Nonperforming assets decreased 7.6% on a linked quarter basis and 32.5% year-over-year. CET1 capital ratio of 9.8% at March 31, 2022, compared with 10.0% at December 31, 2021, driven by strong loan growth.

06:49 EDT U.S. Bancorp CEO says 'healthy trends in consumer and business activity' in Q1 - Andy Cecere, Chairman, President and CEO, U.S. Bancorp said, "In the first quarter, we reported earnings per share of $0.99 and a return on tangible common equity of 16.6%. Our results benefitted from healthy trends in consumer and business activity. We saw very strong loan growth, which drove solid growth in net interest income. Our fee revenue growth was supported by improving business activity and new business wins. Notably, we continued to see good momentum in our payments businesses reflecting both continued cyclical recovery in pandemic impacted industries, particularly travel and entertainment sectors, as well as the benefit from previous investments. We continue to manage our operating expenses prudently, even as we invest for the future, and we continue to benefit from the progress we are making on initiatives aimed at advancing our digital offerings, expanding our payment services capabilities and enhancing our core technology. We continue to work on integration activities related to our planned acquisition of Union Bank and we remain confident the strategic and financial merits of this deal will meaningfully enhance shareholder value and the combination will benefit our customers, our communities and our employees for years to come. Our credit quality remains strong, and we continue to approach credit decisions with a through the cycle lens. In summary, the year is off to a good start, and I would like to thank our employees for their hard work and dedication to serving all our constituents."

06:48 EDT GFL Environmental to divest four liquid waste facilities, three tank farms - GFL Environmental announced that it has reached an agreement with the Canadian Competition Bureau to address concerns raised by the Bureau with the company's acquisition of the solid waste and environmental services businesses of Terrapure Environmental, which acquisition closed on August 17, 2021.GFL worked collaboratively with the Bureau to reach an agreement under which GFL has agreed to divest of four liquid waste facilities and three tank farms, located in Western Canada. These sites were expected to generate annual aggregate revenue of approximately $20 million in 2022. The company is pleased to have reached an arrangement with the Bureau on this matter and will work to complete the proposed divestiture as soon as possible. This agreement now concludes the Bureau's legal action against GFL.

06:47 EDT Merck's V116 vaccine granted Breakthrough Therapy Designation by FDA - Merck's V116, the company's investigational 21-valent pneumococcal conjugate vaccine, has received Breakthrough Therapy Designation from the FDA for the prevention of invasive pneumococcal disease and pneumococcal pneumonia caused by Streptococcus pneumoniae serotypes in adults 18 years of age and older. Phase 3 clinical trials for V116 are to be initiated later this year. The FDA's decision was informed by data from a Phase 1/2 study that assessed the safety, tolerability, and immunogenicity of a single dose of V116 in pneumococcal vaccine-naive adults 18-49 years of age and 50 years of age and older. Full results from the study are planned for presentation in June.

06:33 EDT New Found Gold appoints Collin Kettell as CEO - New Found Gold has appointed Collin Kettell as CEO of and Vijay Mehta has joined as a member of the company's board of directors. As part of a planned transition, Craig Roberts has resigned as CEO and as a director of the company and will continue with the company as a full-time consultant in the role of Lead Advisor. Mehta is co-founder of Arkview Capital, a minority-certified private equity fund based in New York that is focused on investing in diversity-oriented businesses. Prior to founding Arkview, Vijay was a Managing Director at Ziff Brothers Investments, a multi-billion family office based in New York.

06:18 EDT Twitter jumps 13% in premarket trading amid $54.20/share offer from Elon Musk

06:17 EDT Sachem Head comments on revised slate of Director nominees at US Foods - Sachem Head Capital Management, a beneficial owner of approximately 8.7% of the outstanding common stock of US Foods, filed updated preliminary proxy materials with the SEC in connection with US Foods' upcoming 2022 Annual Meeting of Stockholders. Sachem Head previously announced it would be reducing its slate of seven director nominees to five director nominees. It disclosed that Bernardo Hees and Meredith Adler were the two directors withdrawn from the revised slate and that it plans to solicit proxies for the election of James J. Barber, Jr., Scott D. Ferguson, Jeri B. Finard, John J. Harris and David A. Toy at the Annual Meeting. Sachem Head issued the following comment: "We went into this process knowing that Bernardo is a world-class executive and an individual of the highest integrity. Our time spent with him leading up to this point has only reinforced our views, as well as our conviction that his unique operational expertise and accomplished track record would make him an ideal leader to help reinvigorate US Foods. When we made the strategic choice to seek minority instead of majority representation on the Board, Bernardo offered to withdraw his nomination from the process, and we agreed it no longer made sense for him to be part of our slate, given the low likelihood of being able to work with him in the role we had envisioned. We want to thank Bernardo for his valuable insights and the time he devoted to this campaign. We also want to thank Meredith for the time she devoted to this campaign. Whereas we viewed - and continue to view - her recent tenure on the Board of Performance Food Group Company as a positive, the US Foods Board has repeatedly made the point to us and other stockholders that it would force her to recuse herself from virtually any discussions involving competitive strategy. We believe this is a mistake, but in the context of running a minority slate did not want to put stockholders, or Meredith, in a position where the company could effectively negate her presence on the Board, and mutually agreed with Meredith to withdraw her nomination. Sachem Head remains open to reaching a constructive resolution with US Foods that ensures the appropriate level of change takes place. Barring that, we look forward to engaging with our fellow stockholders and achieving the best long-term outcome for all of the company's stakeholders."

06:16 EDT Twitter 'needs to be transformed as a private company,' says Elon Musk - In a letter to Twitter Chairman Bret Taylor, Elon Musk said: "I invested in Twitter as I believe in its potential to be the platform for free speech around the globe, and I believe free speech is a societal imperative for a functioning democracy. However, since making my investment I now realize the company will neither thrive nor serve this societal imperative in its current form. Twitter needs to be transformed as a private company. As a result, I am offering to buy 100% of Twitter for $54.20 per share in cash, a 54% premium over the day before I began investing in Twitter and a 38% premium over the day before my investment was publicly announced. My offer is my best and final offer and if it is not accepted, I would need to reconsider my position as a shareholder. Twitter has extraordinary potential. I will unlock it."

06:14 EDT Elon Musk offers to buy Twitter for $54.20 per share in cash

06:02 EDT JPMorgan announces plans for new global headquarters in New York City - JPMorgan Chase unveiled the design for its new state-of-the-art global headquarters at 270 Park Avenue, reinforcing its commitment to New York City. The 1,388-foot, 60-story skyscraper - designed by Foster + Partners - will be New York City's largest all-electric tower with net zero operational emissions and exceptional indoor air quality that exceeds the highest standards in sustainability, health and wellness. It will help define the modern workplace with 21st century infrastructure, smart technology and 2.5M square feet of flexible and collaborative space that can easily adapt to the future of work. The project is the first under New York City's innovative Midtown East Rezoning plan, which encourages modern office construction and improvements to the business district's public realm and transportation. With this new headquarters commitment, JPMorgan Chase will remain one of New York's largest employers and continue to make a significant impact on the local economy - helping small businesses and supporting additional job growth as the region recovers from the global pandemic. The firm is also making a significant investment to help improve the city's infrastructure and transit system and working closely with the Metropolitan Transportation Authority. The project is expected to be completed by the end of 2025. During the building period alone, the project will create more than 8,000 construction jobs from across 40 local unions - triggering additional economic activity of $2.6 billion for New York City and $3.6 billion for New York State overall. An independent study by Deloitte found that through JPMorgan Chase's tens of thousands of local employees and operations, the firm contributes $29.8 billion in annual economic activity to New York City, stimulating an additional 40,000 jobs across several local industries. In New York State, the firm contributes a total of $39.8 billion annually to the state's economy, stimulating an additional 61,000 jobs overall. The new building will house up to 14,000 employees - replacing an outdated facility designed in the late 1950s for about 3,500 employees. It will offer 2.5 times more outdoor space on the ground level of Park and Madison Avenues, featuring wider sidewalks and a large public plaza on Madison Avenue with natural green space and other amenities geared toward the residents, workers and visitors who frequent the neighborhood on a daily basis.

05:23 EDT ArcelorMittal to acquire 80% of voestalpine HBI plant in Corpus Christi - ArcelorMittal announced it has signed an agreement to acquire an 80% shareholding in voestalpine's Hot Briquetted Iron, or HBI, plant located in Corpus Christi, Texas. voestalpine will retain the remaining 20%. The transaction values the Corpus Christi operations at $1B and closing is subject to customary regulatory approvals. The plant, which was opened in October 2016, is one of the largest of its kind in the world. It has an annual capacity of two million tons of HBI, a feedstock made through the direct reduction of iron ore which is used to produce high-quality steel grades in an electric arc furnace, or EAF, but which can also be used in blast furnaces, resulting in lower coke consumption. HBI is a premium, compacted form of Direct Reduced Iron, or DRI, developed to overcome issues associated with shipping and handling DRI. In parallel with the transaction, ArcelorMittal has signed a long-term offtake agreement with voestalpine to supply an annual volume of HBI commensurate to voestalpine's equity stake to its steel mills in Donawitz and Linz, Austria. The remaining balance of production will be delivered to third parties under existing supply contracts, and to ArcelorMittal facilities, including to AM/NS Calvert in Alabama, upon the commissioning of its 1.5 million ton EAF, expected in the second half of 2023.

05:14 EDT B2Gold reports Q1 gold production 209,365 ounces - Total gold production of 209,365 ounces was 5% above budget, and consolidated gold production of 196,473 ounces from the company's three operating mines, was 4% above budget, with solid performances from all the company's three mines, with each mine exceeding its budgeted production for Q1. Consolidated gold revenue was $366M on sales of 195,100 ounces at an average realized price of $1,874 per ounce